Crescendo Biologics Raises £4.5 Million
Crescendo Biologics, a UK-based developer of fragment antibody technology platforms, has raised £4.5 million in seed funding. Sofinnova Partners led the round, and was joined by Aitua, Avlar BioVentures and the Rainbow Seed Fund.
12 October 2009•4 mins read
